Juno Therapeutics, Inc. (JUNO) Stock Charts JUNO Home News Ratings Charts Warning: This security is no longer trading. Celgene Corporation has completed the acquisition of Juno Therapeutics, Inc. Juno Therapeutics, Inc. (JUNO): $86.96 0.09 (+0.10%) POWR Rating Get Rating Component Grades Growth Get Rating Value Get Rating Momentum NR Stability NR Sentiment Get Rating Quality NR Add JUNO to Watchlist Sign Up Industry: Biotech Industry NR Ranked in industry See All 'A' Rated Buy Stocks Juno Therapeutics, Inc. (JUNO) Performance Graph for POWR Ratings Juno Therapeutics, Inc. (JUNO) Interactive Chart JUNO Chart by TradingView Juno Therapeutics, Inc. (JUNO) Ratings History Chart Free access to the full ratings history for JUNO. Sign up now! Most Popular Stories View All • Does Trump Change Stock Market Outlook? • 3 Streaming Stocks Benefiting from Cord-Cutting Trends • 3 Gold Stocks to Buy as Safe-Haven Demand Grows • 3 AI Stocks Transforming Industries and Driving Future Growth • Updated Stock Market Expectations View All Top stories Get Free Updates Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com! Subscribe Get Free Updates Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!
